Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
CHICAGO, Oct. 18, 2017 -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced it expects to release financial results for the three months ended September 30, 2017 after market close on Tuesday, October 31, 2017.
R1’s management team will host a conference call on October 31 at 3:30 p.m. CT (4:30 p.m. ET) to discuss the results and business outlook. To participate, please dial 877-880-5884 (631-601-2894 outside the U.S. and Canada) using conference code number 3793709. A live webcast and replay of the call will be available at the Investor Relations section of the Company’s website at r1rcm.com.
About R1 RCM
R1 serves as the one revenue cycle management partner for select hospitals and healthcare systems regardless of their payment models, partner engagement structures, or settings of care. The Company uses a proven operating model based on the R1 Performance StackSM designed to fit seamlessly into any healthcare organization’s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability. To learn more, visit r1rcm.com.
Contact:
R1 RCM Inc.
Investor and Media Relations:
Atif Rahim
312.324.5476
[email protected]
